Citing failure to meet child-resistant closure requirement, Merck has advised that all bottles should be examined for cracks and that affected bottles should be kept out of children’s reach. / read more /
Mylan received an FDA warning letter citing violations at its Agila Specialty Formulation Facility, Sterile Products Division, and Onco Therapies Limited sites in India. / read more /
Kate Kuhrt, senior director, Generics and Biotech, Thomson Reuters, shares insights on sourcing trends, supply chain challenges, the emerging market outlook, and how it affects European pharmaceutical manufacturers. / read more /
After a long wait for the new elemental impurities guidelines, the bio/pharma industry must now look ahead to implementation and take action. / read more /
Randy Wald, senior research fellow at Bend Research, part of Capsugel Dosage Form Solutions looks at advances in excipients and the impact on formulation development and manufacturing processes. / read more /
Experts from Dow Pharma & Food Solutions discuss the versatility of solid dispersions in solubility enhancement and the importance of pairing the API to the optimal polymer. / read more /
Companies in the US will now have the opportunity to tap into Hermes Pharma’s expertise in effervescent and chewable tablets, instant drinks, lozenges, and orally disintegrating granules. / read more /
Andrew Bulpin, executive vice president of EMD Millipore’s Process Solutions Business, speaks to Pharmaceutical Technology about the trends shaping the biopharmaceutical manufacturing industry. / read more /
Cloud computing has made it easier for pharma companies and their contract partners to gain visibility into their combined supply chains. / read more /
Ion exchange resins have long been in the formulator’s toolkit, but only recently have they been used as excipients. Learn the value and benefits ion exchange resins bring to drug formulation challenges such as taste masking, abuse deterrence, controlled release, and more. Sponsored by: Dow
Increasing requests from regulatory agencies have focused on evaluation of APIs and drug products during shipment. However, little guidance has been provided on how to address these concerns. This webinar will address these questions and explore approaches to assessing stability of biologic APIs and small molecule drug products throughout shipment. Sponsored by: Patheon
Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid-dosage form principles such as oral solid-dosage forms, powders, mixing and blending, excipients, tableting, and coating. Drug delivery system manufacturing professionals can use the solid dosage manufacturing books to stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development. / Click here /
This eBook examines how advances in technology, equipment, excipients, analytical techniques, software, and manufacturing practices are facilitating the development, scale up, manufacturing, efficacy, and delivery of solid- and semi-solid dosage forms.
